Zheran J. Liu

Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Oncolytic virus-delivered CEACAM6/CD3 BiTEs combine with PD-1 blockade to achieve synergistic anticancer efficacy.

Oncolytic virus-delivered CEACAM6/CD3 BiTEs combine with PD-1 blockade to achieve synergistic anticancer efficacy.

Journal: Pharmacological research

Published: April 29, 2026

Mitochondria-targeted strategies in cancer radiotherapy: from ROS regulation to immunogenic cell death.

Mitochondria-targeted strategies in cancer radiotherapy: from ROS regulation to immunogenic cell death.

Journal: Frontiers in cell and developmental biology

Published: April 21, 2026

Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 Trial.

Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 Trial.

Journal: Cancer management and research

Published: March 30, 2026

Beyond apoptosis: nanomedicine enabled reprogramming of tumor cell death for next-generation radiosensitization.

Beyond apoptosis: nanomedicine enabled reprogramming of tumor cell death for next-generation radiosensitization.

Journal: Journal of nanobiotechnology

Published: March 27, 2026

Fullerene for Reducing Acute Radiation Dermatitis in Patients Undergoing Radiotherapy for Head and Neck Cancer: A Phase II, Double-Blind, Randomized Controlled Trial.

Fullerene for Reducing Acute Radiation Dermatitis in Patients Undergoing Radiotherapy for Head and Neck Cancer: A Phase II, Double-Blind, Randomized Controlled Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 20, 2026

Antibiotic exposure and cancer risk: an umbrella review elucidating the direction of risk across 14 malignancies.

Antibiotic exposure and cancer risk: an umbrella review elucidating the direction of risk across 14 malignancies.

Journal: Journal of public health (Oxford, England)

Published: February 04, 2026

From binary senescence to state-resolved senotherapy in cancer: Therapeutic windows from heterogeneity.

From binary senescence to state-resolved senotherapy in cancer: Therapeutic windows from heterogeneity.

Journal: Ageing research reviews

Published: February 03, 2026

Correction: Association between statin use and immune-related adverse events in patients treated with immune checkpoint inhibitors: analysis of the FAERS database.

Correction: Association between statin use and immune-related adverse events in patients treated with immune checkpoint inhibitors: analysis of the FAERS database.

Journal: Frontiers in immunology

Published: December 16, 2025

Multidisciplinary Team Support for Patients With Head and Neck Cancer Receiving Radiotherapy: A Randomized Clinical Trial.

Multidisciplinary Team Support for Patients With Head and Neck Cancer Receiving Radiotherapy: A Randomized Clinical Trial.

Journal: JAMA network open

Published: December 15, 2025

Pan-immune-inflammation value as an independent prognostic marker in patients with brain metastases.

Pan-immune-inflammation value as an independent prognostic marker in patients with brain metastases.

Journal: Frontiers in oncology

Published: October 03, 2025

Correction: Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167).

Correction: Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167).

Journal: Cancer immunology, immunotherapy : CII

Published: September 29, 2025

ZBP1 Drives CD8+ T cell-mediated anti-tumor immunity in head and neck squamous cell carcinoma.

ZBP1 Drives CD8+ T cell-mediated anti-tumor immunity in head and neck squamous cell carcinoma.

Journal: PLoS genetics

Published: July 24, 2025

Showing 1-12 of 83

Last Updated: 09/26/2026